Abstract
High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide-alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography-mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter.
Original language | English |
---|---|
Pages (from-to) | 10341-10356 |
Number of pages | 16 |
Journal | Journal of Medicinal Chemistry |
Volume | 65 |
Issue number | 15 |
DOIs | |
State | Published - 11 Aug 2022 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022 American Chemical Society.
Funding
N.L. is the incumbent of the Alan and Laraine Fischer Career Development Chair. N.L. acknowledges funding from the Israel Science Foundation (grant no. 2462/19), the Israel Cancer Research Fund, and the Moross Integrated Cancer Center. N.L. is also supported by the Estate of Emile Mimran, Rising Tide Foundation, Honey and Dr. Barry Sherman Lab, Dr. Barry Sherman Institute for Medicinal Chemistry and Nelson P. Sirotsky.
Funders | Funder number |
---|---|
Estate of Emile Mimran | |
Moross Integrated Cancer Center | |
Israel Cancer Research Fund | |
Israel Science Foundation | 2462/19 |
Rising Tide Foundation |